SelectQuote (NYSE:SLQT) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of SelectQuote (NYSE:SLQT) to a hold rating in a research note published on Saturday,Wall Street Zen reports.

Several other research analysts have also weighed in on the company. Zacks Research raised SelectQuote from a “strong sell” rating to a “hold” rating in a research report on Monday, October 26th. Weiss Ratings cut shares of SelectQuote from a “sell (d+)” rating to a “sell (d)” rating in a report on Monday, August 17th. One analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $3.00.

SelectQuote Stock Down 10.9%

NYSE:SLQT traded down $0.05 during trading hours on Friday, reaching $0.44. 2,464,137 shares of the stock were exchanged, compared to its average volume of 1,753,939. SelectQuote has a twelve month low of $0.30 and a twelve month high of $1.76. The firm has a 50 day moving average of $0.42 and a 200 day moving average of $0.73. The stock has a market cap of $78.42 million, a PE ratio of -14.57 and a beta of 2.01. The company has a debt-to-equity ratio of 1.16, a current ratio of 7.48 and a quick ratio of 7.48.

SelectQuote (NYSE:SLQT) last issued its quarterly earnings results on Wednesday, November 4th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.12. The firm had revenue of $280.01 million for the quarter, compared to analyst estimates of $277.91 million. SelectQuote had a net margin of 4.61% and a return on equity of 22.48%. On average, equities analysts expect that SelectQuote will post -0.25 earnings per share for the current year.

Insider Buying and Selling at SelectQuote

In other SelectQuote news, President Robert Grant bought 79,801 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The shares were acquired at an average cost of $0.51 per share, with a total value of $40,698.51. Following the acquisition, the president owned 3,386,491 shares of the company’s stock, valued at $1,727,110.41. The trade was a 2.41% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Donald L. Hawks III purchased 223,402 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The stock was acquired at an average price of $0.46 per share, for a total transaction of $102,764.92. Following the purchase, the director owned 763,214 shares in the company, valued at $351,078.44. This trade represents a 41.39% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 919,905 shares of company stock worth $446,916 in the last three months. 11.60% of the stock is owned by insiders.

Hedge Funds Weigh In On SelectQuote

Several large investors have recently modified their holdings of the stock. Marshall Wace LLP boosted its holdings in shares of SelectQuote by 213.8% during the 3rd quarter. Marshall Wace LLP now owns 866,887 shares of the company’s stock worth $355,000 after buying an additional 590,606 shares during the period. Commonwealth Equity Services LLC grew its stake in SelectQuote by 541.1% in the 3rd quarter. Commonwealth Equity Services LLC now owns 181,939 shares of the company’s stock valued at $74,000 after buying an additional 153,562 shares during the last quarter. SMH Capital Advisors Inc. bought a new position in SelectQuote in the 3rd quarter valued at about $47,000. Fragasso Financial Advisors Inc bought a new position in SelectQuote in the 3rd quarter valued at about $61,000. Finally, Squarepoint Ops LLC bought a new position in SelectQuote in the 2nd quarter valued at about $536,000. 34.59% of the stock is owned by institutional investors.

About SelectQuote

SelectQuote, Inc. operates a direct-to-consumer insurance distribution platform that helps consumers compare coverage from multiple insurance providers. Its licensed agents assist customers with evaluating options and selecting policies. The company offers Medicare-related products, including Medicare Advantage, Medicare Supplement and prescription drug plans, as well as life, auto and home insurance. Its services also include SelectRx, which provides pharmacy and medication-management services.